title: Postoperative radical radiotherapy with concurrent weekly intra-arterial cis-platinum for treatment of malignant glioma: a pilot study.
abstract: Twelve patients with histologically proven malignant glioma have been treated with a combination of intra-arterial (IA) cis-platinum (CDDP) and radical radiation therapy (RT). Chemotherapy consisted of intracarotid (IC) CDDP, 40-60 mg/m2, weekly, repeated for 3-5 treatments. Radiation therapy consisted of whole-brain irradiation 5000 cGy in 5 weeks, plus a cone-down boost (1000 cGy in one week) to the primary tumour lesion. Ocular toxicity derived from IC chemotherapy was observed in 3 out of 41 procedures analyzed (7%). Results in tumour response assessed by computed tomography (CT) showed 5 complete remissions, 6 partial remissions and one patient was not evaluable. The median survival time for the entire group was 10 months. Median survival time in patients with complete response is 17 months, and 10 months in patients with partial response. Four patients are still alive with a follow-up ranging from 6+ to 27+ months.
authors.affiliation: Department of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain.
authors.forename: F A
authors.initials: FA
authors.lastname: Calvo
authors.forename: C
authors.initials: C
authors.lastname: Dy
authors.forename: I
authors.initials: I
authors.lastname: Henriquez
authors.forename: V
authors.initials: V
authors.lastname: Hidalgo
authors.forename: I
authors.initials: I
authors.lastname: Bilbao
authors.forename: M
authors.initials: M
authors.lastname: Santos
mesh_terms: D000328:Adult; D000368:Aged; D001921:Brain / Q000528:radiation effects; D001932:Brain Neoplasms / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D005910:Glioma / Q000628:therapy*; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011182:Postoperative Care
chemical_list: D002945:Cisplatin